Low body mass index (BMI)/age z-scores are frequent features in type 2 spinal muscular atrophy (SMA), according to a new study published in the European Journal of Pediatrics. Moreover, BMI decreases as age increases.

The results showed that patients with low BMI/age z-scores at baseline were at higher risk of developing more reductions. This finding highlights the need to carefully monitor weight and BMI/age z-scores in patients with type 2 SMA.

“Further studies, including assessments of chewing and swallowing and of lean/fat body mass, will help to better understand the possible mechanisms underlying weight issues,” the researchers said.


Continue Reading

To establish potential differences in BMI in relation to ventilation, motor function, and SMN2 gene copy number, a team of researchers led by Eugenio Mercuri, MD, PhD, analyzed a large cohort of 102 patients with type 2 SMA aged 0 to 20 years. The researchers collected data from the patients for a total of 344 visits.

Read more about SMA etiology

During these visits, the weight of the patients ranged from 3.9 kg to 83 kg. Their BMIs ranged from 8.4 to 31.6 with 28% of patients being underweight and 9% of them being overweight.

The BMI/age z-scores were relatively stable below 5 years of age with an increasing number of patients being underweight after 5 years of age. The BMI/age z-scores of patients were wider in the range after 13 years of age.

There was also a difference in the BMI/age z-scores among the different age subgroups, ie below 5 years of age, between 5 and 12 years of age, and at 13 years of age and above. Baseline BMI/age z-scores and gender were significantly contributing to the changes but other variables were not.

A reduction in BMI/age z-score over time depends on BMI/age z-score at baseline and on gender, the researchers said. Therefore, the underscores need to regularly assess anthropometric factors in patients with type 2 SMA.

Reference

Ferrantini G, Coratti G, Onesimo R, et al. Body mass index in type 2 spinal muscular atrophy: a longitudinal study. Eur J Pediatr. Published online January 19, 2022. doi:10.1007/s00431-021-04325-3